Meena S, Wajs-Bonikowska A, Girawale S, Imran M, Poduwal P, Kodam K
Molecules. 2024; 29(13).
PMID: 38999189
PMC: 11243205.
DOI: 10.3390/molecules29133237.
Chowdhury Z, Jamal T, Ahammad I, Bhattacharjee A, Lamisa A, Jani J
Heliyon. 2023; 9(11):e21466.
PMID: 38034688
PMC: 10682543.
DOI: 10.1016/j.heliyon.2023.e21466.
de Obeso Fernandez Del Valle A, Scheckhuber C, Chavaro-Perez D, Ortega-Barragan E, Maciver S
Microorganisms. 2023; 11(4).
PMID: 37110414
PMC: 10142586.
DOI: 10.3390/microorganisms11040992.
Liu T, Luo H, Gao F
PLoS One. 2021; 16(4):e0250380.
PMID: 33886641
PMC: 8061932.
DOI: 10.1371/journal.pone.0250380.
Uddin R, Siraj B, Rashid M, Khan A, Ahsan Halim S, Al-Harrasi A
Pathogens. 2020; 9(5).
PMID: 32408506
PMC: 7281720.
DOI: 10.3390/pathogens9050368.
Pharmacodynamics of Ceftiofur Selected by Genomic and Proteomic Approaches of Isolated from the Flounder, .
Boby N, Abbas M, Lee E, Park S
Int J Genomics. 2020; 2020:4850290.
PMID: 32318593
PMC: 7150728.
DOI: 10.1155/2020/4850290.
Species-specific transcriptional profiles of the gut and gut microbiome of Ceratitis quilicii and Ceratitis rosa sensu stricto.
Khamis F, Mireji P, Ombura F, Malacrida A, Awuoche E, Rono M
Sci Rep. 2019; 9(1):18355.
PMID: 31798006
PMC: 6892911.
DOI: 10.1038/s41598-019-54989-z.
New insights on human essential genes based on integrated analysis and the construction of the HEGIAP web-based platform.
Chen H, Zhang Z, Jiang S, Li R, Li W, Zhao C
Brief Bioinform. 2019; 21(4):1397-1410.
PMID: 31504171
PMC: 7373178.
DOI: 10.1093/bib/bbz072.
Identification of potential drug targets and inhibitor of the pathogenic bacteria 2a through the subtractive genomic approach.
Oany A, Mia M, Pervin T, Hasan M, Hirashima A
In Silico Pharmacol. 2019; 6(1):11.
PMID: 30607324
PMC: 6314800.
DOI: 10.1007/s40203-018-0048-2.
What bacteria want.
Galperin M
Environ Microbiol. 2018; 20(12):4221-4229.
PMID: 30187651
PMC: 7020242.
DOI: 10.1111/1462-2920.14398.
A Comprehensive Overview of Online Resources to Identify and Predict Bacterial Essential Genes.
Peng C, Lin Y, Luo H, Gao F
Front Microbiol. 2017; 8:2331.
PMID: 29230204
PMC: 5711816.
DOI: 10.3389/fmicb.2017.02331.
Finding Potential Therapeutic Targets against through Proteome Exploration.
Hossain M, Khan M, Hashem A, Islam M, Morshed M, Keya C
Front Microbiol. 2016; 7:1817.
PMID: 27920755
PMC: 5118456.
DOI: 10.3389/fmicb.2016.01817.
Pangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.
Hassan A, Naz A, Obaid A, Paracha R, Naz K, Awan F
BMC Genomics. 2016; 17(1):732.
PMID: 27634541
PMC: 5025611.
DOI: 10.1186/s12864-016-2951-4.
Critical controllability in proteome-wide protein interaction network integrating transcriptome.
Ishitsuka M, Akutsu T, Nacher J
Sci Rep. 2016; 6:23541.
PMID: 27040162
PMC: 4819195.
DOI: 10.1038/srep23541.
Characterization of parasite-specific indels and their proposed relevance for selective anthelminthic drug targeting.
Wang Q, Heizer E, Rosa B, Wildman S, Janetka J, Mitreva M
Infect Genet Evol. 2016; 39:201-211.
PMID: 26829384
PMC: 4789095.
DOI: 10.1016/j.meegid.2016.01.025.
Study of Functional and Allosteric Sites in Protein Superfamilies.
Suplatov D, Svedas V
Acta Naturae. 2016; 7(4):34-45.
PMID: 26798490
PMC: 4717248.
Identification of potential drug targets by subtractive genome analysis of Escherichia coli O157:H7: an in silico approach.
Mondal S, Ferdous S, Jewel N, Akter A, Mahmud Z, Islam M
Adv Appl Bioinform Chem. 2015; 8:49-63.
PMID: 26677339
PMC: 4677596.
DOI: 10.2147/AABC.S88522.
Protective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model.
Kumar A, Hays M, Lim F, Foster L, Zhou M, Zhu G
PLoS Negl Trop Dis. 2015; 9(8):e0003924.
PMID: 26244636
PMC: 4526226.
DOI: 10.1371/journal.pntd.0003924.
Treponema pallidum putative novel drug target identification and validation: rethinking syphilis therapeutics with plant-derived terpenoids.
Dwivedi U, Tiwari S, Singh P, Singh S, Awasthi M, Pandey V
OMICS. 2015; 19(2):104-14.
PMID: 25683888
PMC: 4322953.
DOI: 10.1089/omi.2014.0154.
Genome-wide Analysis of Mycoplasma hominis for the Identification of Putative Therapeutic Targets.
Parvege M, Rahman M, Hossain M
Drug Target Insights. 2015; 8:51-62.
PMID: 25574133
PMC: 4263438.
DOI: 10.4137/DTI.S19728.